EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›BA-PA

BA-PA

BOEING CO

Next earnings ≈ Jul 22, 2026 · est. from filing cadence

Last earnings +4.3% on 2026-04-22

Hold
$68.01
▼ -0.37%
$68.01▲ +1.49%
over 1Y
L $58.71EODHDH $78.78
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-0.4%
1W-0.4%
1M-4.5%
3M+10.2%
YTD-5.1%
1Y+1.5%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Undervalued
Filings
Watch
Hold
Conviction
Horizon
Medium (3–12mo)

Revenue grew 34.5% YoY; but thin net margin (2.5%).

Revenue (FY2025) $89.5B · FY2025

The read

Middling fundamentals offset by an attractive price (~39% below fair value) — worth a look on the value angle.

BOEING CO shows $89.5B in FY2025 revenue (+34.5% YoY), a 2.5% net margin, and 41.0% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$62.3B$66.6B$77.8B$66.5B$89.5B
Gross profit$3.05B$3.53B$7.72B-$1.99B$4.29B
Operating income-$2.87B-$3.52B-$773M-$10.7B$4.28B
Net income-$4.20B-$4.93B-$2.22B-$11.8B$2.23B
Diluted EPS-$7.15-$8.30-$3.67-$18.36$2.48
Net margin-6.7%-7.4%-2.9%-17.8%2.5%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$105B
EV / EBITDA16.8
EV / Sales1.2
EV / FCF—
P / FCF—
PEG (trailing)0.23
Earnings yield4.2%
FCF yield-3.5%

Quality & risk

ROIC (est.)5.0%
Free cash flow-$1.88B
Total debt$62.3B
Net cash-$51.4B
Altman Z-Score1.10 distress
Piotroski F-Score6/9

Capital returns

Buyback yield5.0%
Dividend yield (est.)0.6%
Shareholder yield5.6%
Shares Δ YoY+4.7%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Earnings results2026-04-22
  2. 10-Q Quarterly report2026-04-22
  3. 8-K Shareholder vote2026-04-17
  4. DEF 14A Proxy statement2026-03-06
  5. 10-K Annual report2026-01-30
  6. 8-K Earnings results2026-01-27
  7. 8-K Reg FD disclosure2025-12-08
  8. 8-K Officer / director change2025-12-03
  9. 8-K Earnings results2025-10-29

Recent filings

all on EDGAR ↗
3Period ending 2026-06-232026-06-26open ↗11-KPeriod ending 2025-12-312026-06-16open ↗SDFiling2026-05-26open ↗4Period ending 2026-05-202026-05-22open ↗SCHEDULE 13GFiling2026-05-14open ↗SCHEDULE 13GFiling2026-04-29open ↗10-QPeriod ending 2026-03-312026-04-22open ↗8-KPeriod ending 2026-04-222026-04-22open ↗8-KPeriod ending 2026-04-172026-04-17open ↗4Period ending 2026-04-012026-04-03open ↗4Period ending 2026-04-012026-04-03open ↗4Period ending 2026-04-012026-04-03open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueB+
GrowthA+
ProfitabilityB-
Financial healthC+
Momentum—
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓Return on equity above 15%
  • ✗Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$94.24

Undervalued +39% vs price

cheapfair valueexpensive

Modified Graham: EPS $2.48 × (8.5 + 1.5 × 22.0% growth) × 0.94 quality = 38.0× multiple. An estimate, not a price target.

Revenue
$89.5B
+34.5% YoY
Net margin
2.5%
ROE
41.0%
P/E
27.4

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$89.5B+34.5%
Net income$2.23B+118.9%
Gross profit$4.29B+315.4%
Operating income$4.28B+140.0%
Diluted EPS$2.48+113.5%
Cash & equivalents$10.9B-20.9%
Total assets$168B+7.6%
Total liabilities$163B+1.6%
Stockholders' equity$5.45B+239.6%
Gross: 4.8%Op.: 4.8%L/E: 29.85x

Frequently asked

Is BOEING CO (BA-PA) a buy?
BA-PA currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Revenue grew 34.5% YoY; but thin net margin (2.5%).
What is BA-PA's fair value?
A Modified-Graham model based on BA-PA's SEC fundamentals estimates a fair value of about $94.24. It is an estimate from reported earnings, not a price target.
Is BA-PA overvalued or undervalued?
Against a Modified-Graham fair-value estimate, BA-PA currently appears undervalued relative to its SEC-grounded earnings power.
What is BOEING CO's quality score?
BA-PA scores 74.21568627450979/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000012927, latest 10-Q filed 2026-04-22) · EODHD · as of 6/26/2026, 7:48:19 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 1 open-market buy · 0 sales

2026-05-20
TILDEN BRADLEY D
Director
Buy1.37K @ $218.50$299K

Dividends

Quarterly
Yield (TTM)
4.4%
Annual / share
$3.00
Last ex-date
2026-04-01
Last amount
$0.75
ex 2026-04-01$0.75
ex 2025-12-31$0.75
ex 2025-10-01$0.75
ex 2025-07-01$0.75
ex 2025-04-01$0.75
ex 2024-12-31$0.63

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-22—▲ +4.34%8-K ↗
2026-01-27—▼ -1.05%8-K ↗
2025-10-29—▼ -3.04%8-K ↗
2025-07-29—▼ -3.66%8-K ↗
2025-04-23—▲ +4.86%8-K ↗
2025-01-28—▲ +0.78%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Vs tracked universe

compare →

1043 tracked peers · median

EDGAR Score74 vs 67
Revenue growth34.5% vs 7.1%
Net margin2.5% vs 10.5%
Return on equity41.0% vs 12.3%
P/E27.4 vs 25.5